Epidemiology of invasive fungal infections in Latin America
J Sifuentes-Osornio, DE Corzo-León… - Current fungal infection …, 2012 - Springer
The pathogenic role of invasive fungal infections (IFIs) has increased during the past two
decades in Latin America and worldwide, and the number of patients at risk has risen …
decades in Latin America and worldwide, and the number of patients at risk has risen …
Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial …
MA Pfaller, M Castanheira, SA Messer, GJ Moet… - … and infectious disease, 2010 - Elsevier
The variation in Candida spp. causing bloodstream infection (BSI) and the frequency of
resistance to fluconazole by patient age have been previously described. However, similar …
resistance to fluconazole by patient age have been previously described. However, similar …
Background changing patterns of neonatal fungal sepsis in a developing country
Background: Candida albicans is the predominant isolate in many neonatal fungal
bloodstream infections (BSIs), so fluconazole is used as empiric antifungal therapy. Aim: To …
bloodstream infections (BSIs), so fluconazole is used as empiric antifungal therapy. Aim: To …
Antifungal and anti-biofilm activity of the first cryptic antimicrobial peptide from an archaeal protein against Candida spp. clinical isolates
E Roscetto, P Contursi, A Vollaro, S Fusco… - Scientific reports, 2018 - nature.com
Candida species cause cutaneous and systemic infections with a high mortality rate,
especially in immunocompromised patients. The emergence of resistance to the most …
especially in immunocompromised patients. The emergence of resistance to the most …
Examination of Potential Virulence Factors of Candida tropicalis Clinical Isolates From Hospitalized Patients
Candida tropicalis has been reported to be one of the Candida species which is most likely
to cause bloodstream and urinary tract infections in hospitalized patients. Accordingly, the …
to cause bloodstream and urinary tract infections in hospitalized patients. Accordingly, the …
[HTML][HTML] Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in …
S Córdoba, W Vivot, ME Bosco-Borgeat… - Revista argentina de …, 2011 - SciELO Argentina
ABSTRACT The Mycology Department of the Instituto Nacional de Enfermedades
Infecciosas" Dr. C. Malbrán", conducted the Second National Multicenter Survey on …
Infecciosas" Dr. C. Malbrán", conducted the Second National Multicenter Survey on …
Antifungal effect of 4-arylthiosemicarbazides against Candida species. Search for molecular basis of antifungal activity of thiosemicarbazide derivatives
A Siwek, J Stefańska, K Dzitko, A Ruszczak - Journal of molecular …, 2012 - Springer
The in vitro antifungal potency of six series of 4-arylthiosemicarbazides was evaluated. Two
isoquinoline derivatives with an ortho-methoxy or ortho-methyl group at the phenyl ring were …
isoquinoline derivatives with an ortho-methoxy or ortho-methyl group at the phenyl ring were …
Bacteriocin-Like Inhibitory Substances from Probiotics as Therapeutic Agents for Candida Vulvovaginitis
Probiotics can potentially prevent and treat diseases. We examined the inhibitory activity of
bacteriocin-like inhibitory substances (BLISs) from potentially probiotic lactobacilli and …
bacteriocin-like inhibitory substances (BLISs) from potentially probiotic lactobacilli and …
Antifungal Activity of Extracts and Isolated Compounds from Buchenavia Tomentosa on Candida Albicans and non-albicans
GR Teodoro, FL Brighenti, ACB Delbem… - Future …, 2015 - Taylor & Francis
Aim: This study aimed to evaluate the antifungal activity of Buchenavia tomentosa extract
and bioactive compounds on six Candida species. Materials & methods: The antimicrobial …
and bioactive compounds on six Candida species. Materials & methods: The antimicrobial …
A promising approach of overcoming the intrinsic resistance of Candida krusei to fluconazole (FLC) – combining tacrolimus with FLC
H Li, C Zhang, Z Chen, W Shi, S Sun - FEMS yeast research, 2014 - academic.oup.com
Candida krusei is intrinsically resistant to fluconazole (FLC). This study aimed to investigate
whether tacrolimus (FK506) could enhance the susceptibility of FLC against C. krusei. The …
whether tacrolimus (FK506) could enhance the susceptibility of FLC against C. krusei. The …